These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results Terminated 2004-002208-14 Duration of Amiodarone therapy required for new post cardiac surgery atrial fibrillation. 2008-06-24 due-trials
Other 2004-003825-29 MAGNET - a randomised placebo controlled trial of the use of nebulised magnesium sulphate in moderate/severe acute asthma in childhood not-yet-due
Reported results 2005-002777-68 The effects of rosuvastatin therapy on glucose metabolism in non-diabetic renal transplant recipients with a focus on insulin sensitivity and pancreatic beta islet cell function 2007-05-21 due-trials
Reported results 2005-002784-91 A Randomized, Multicentre, Parallel Group Single-Blind Study to Assess the Efficacy and Safety of Dosing Mesalazine 800 mg Tablets (Asacol®) at 2.4 g Once Daily versus Divided Doses Three Times Daily ... 2010-07-01 due-trials
Not reported Terminated 2005-003197-17 The Metabolic,Vascular and Inflammatory effects of Conjugated Linoleic acid in patients with the Metabolic Syndrome. 2008-03-07 due-trials
Reported results 2005-004995-20 A Prospective, Single-Arm, Open-label Study to Investigate the Efficacy and Safety of Intravesical Injection of Botulinum Toxin Type-A (500 Units Dysport®) for the Management of Idiopathic Overactive ... 2008-08-21 due-trials
Reported results Terminated 2005-004996-40 A Prospective, Single-Arm, Open-label Study to Investigate the Efficacy and Safety of Intravesical Injection of Botulinum Toxin Type-A (750 Units Dysport®) for the Management of Neurogenic Detrusor Ov... 2008-08-21 due-trials
Reported results 2006-000024-13 Does Aggressive management with early high dose aspirin reduce the hypercoagulability of platelets following coronary artery bypass grafting? 2009-03-03 due-trials
Reported results 2006-003333-33 A randomised controlled, open label, phase II pilot study comparing the toxicity of rituximab plus CHOP chemotherapy with rituximab plus CHOP chemotherapy and bortezomib in adults with newly diagnosed... 2012-03-01 due-trials
Reported results 2009-017369-47 An in-vitro observational pilot study of the role of gamma delta T cells in the acute phase reaction to intravenous bisphosphonate; in blood samples donated by patients receiving intravenous bisphosph... 2013-01-31 due-trials
Reported results Terminated 2010-022075-66 A Single Centre Physiological Study of Glucose Metabolism Before and After Tacrolimus Withdrawal For Deteriorating Kidney Function In Renal Transplant Recipients 2012-01-19 due-trials
Other 2017-002602-12 Improving Transplant Opportunities for Patients who are Sensitised (ITOPS) – a feasibility, randomised, controlled phase III trial not-yet-due